Skip to main content
Premium Trial:

Request an Annual Quote

MolecularMD Licenses Rights to Commercialize Technology Aimed at Endometrial Cancer

NEW YORK (GenomeWeb News) – MolecularMD said today it has secured the rights to commercialize IP surrounding fibroblast growth factor receptor 2 activating mutations for diagnostic, prognostic, and predictive purposes in human endometrial cancer.

Rights to the IP are jointly held by Washington University in St. Louis and the Translational Genomics Research Institute.

Activating mutations in FGFR2 have been identified in 10 percent of primary uterine tumors that have been studied, the Portland, Ore.-based MolecularMD, said, adding endometrial carcinoma is the second leading cause of gynecologic cancer mortality in the developed world. In the US, an estimated 47,000 new cases were diagnosed in 2012, with 8,000 deaths.

Several therapies that target mutant FGFR2 are under development, and knowledge about a patient's FGFR2 status could aid in identifying new therapies and improve the survival of patients, MolecularMD said.

Financial terms of the deal were not disclosed.

Today's announcement follows an agreement at the start of the year in which MolecularMD licensed a genetic marker, LKB1, to develop diagnostic assays for non-small cell lung cancer.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.